- Home
- SYRE vs ASIC Comparison
SYRE vs ASIC Comparison
Compare SYRE & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- ASIC
- Stock Information
- Founded
- SYRE 2013
- ASIC 2018
- Country
- SYRE United States
- ASIC United States
- Employees
- SYRE N/A
- ASIC N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- ASIC Property-Casualty Insurers
- Sector
- SYRE Health Care
- ASIC Finance
- Exchange
- SYRE Nasdaq
- ASIC Nasdaq
- Market Cap
- SYRE 1.1B
- ASIC 1.0B
- IPO Year
- SYRE 2016
- ASIC 2025
- Fundamental
- Price
- SYRE $17.38
- ASIC $22.64
- Analyst Decision
- SYRE Buy
- ASIC Strong Buy
- Analyst Count
- SYRE 5
- ASIC 4
- Target Price
- SYRE $55.00
- ASIC $27.00
- AVG Volume (30 Days)
- SYRE 490.8K
- ASIC 119.5K
- Earning Date
- SYRE 08-05-2025
- ASIC 08-11-2025
- Dividend Yield
- SYRE N/A
- ASIC N/A
- EPS Growth
- SYRE N/A
- ASIC N/A
- EPS
- SYRE N/A
- ASIC 0.15
- Revenue
- SYRE N/A
- ASIC $378,302,000.00
- Revenue This Year
- SYRE N/A
- ASIC $13.81
- Revenue Next Year
- SYRE N/A
- ASIC $46.67
- P/E Ratio
- SYRE N/A
- ASIC $147.57
- Revenue Growth
- SYRE N/A
- ASIC 42.48
- 52 Week Low
- SYRE $10.91
- ASIC $18.50
- 52 Week High
- SYRE $40.26
- ASIC $25.30
- Technical
- Relative Strength Index (RSI)
- SYRE 57.01
- ASIC N/A
- Support Level
- SYRE $15.73
- ASIC N/A
- Resistance Level
- SYRE $17.42
- ASIC N/A
- Average True Range (ATR)
- SYRE 0.89
- ASIC 0.00
- MACD
- SYRE 0.07
- ASIC 0.00
- Stochastic Oscillator
- SYRE 86.50
- ASIC 0.00
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About ASIC Ategrity Specialty Insurance Company Holdings Common Stock
Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.